For this purpose, we evaluated the effects of the H4R-selective antagonist, JNJ7777120, and of the H4R agonist, VUF8430, in an in vivo model of bleomycin-induced lung fibrosis, in PARP-1 knock-out and in wild-type mice. Here, PARP1 is linked to pulmonary fibrosis.